Identification of predictive biomarkers of immunotherapy efficacy in cancer patients through analysis of plasma proteomics
Date: Oct 21, 2021
Professor Antoine Italiano (Head of Early Phase Trials and Sarcoma Unit, Institut Bergonié) presents how protein biomarkers are providing an improve understanding and characterization of cancer patients stratification within Immuno-Oncology.
During this webinar Professor Antoine Italiano (Head of Early Phase Trials and Sarcoma Unit, Institut Bergonié, france) presents Identification of predictive biomarkers of immunotherapy efficacy in cancer patients through analysis of plasma proteomics.
Protein biomarkers in plasma: revealing biological insights into tumor microenvironment
This webinar explore how an extensive plasma proteomic analysis revealed biological insights about the tumor microenvironment in melanoma patients after immune checkpoint blockade and helped them to identify composite biomarkers to better predict sensitivity and response to immunotherapy.
12 Aug 2021
- Application focus
Integrating NGS proteomics with genomics to improve immunotherapy outcomes in oncology
We highlight how Olink® Explore 3072 supported biomarker discovery in the ASTRUM-005 trial of serplulimab in ES-SCLC. A 15-protein signature predicted treatment response, with additional genomic and hematological markers improving patient stratification and outcomes.
23 Apr 2025
- Product insights
A Complete Solution for Identifying Protein Signatures: From Sample to Actionable Results
Explore how the Olink® Signature Q100 benchtop system and NPX Signature software are part of a complete solution for generating meaningful protein signatures, from study design to data interpretation.
03 Apr 2025